Morning News Round-up:

Ø  Rail Budget focuses on investment in critical areas: EY

Ø  BRICS members to have equal share in new bank

Ø  Railway freight rate for grains and pulses up 10%

Ø  BEL, Rolta chosen for Defence Ministry’s BMS project

Ø  Reliance, Axis MFs get nod to raise stake in MCX

Ø  DLF IPO case: Sebi imposes Rs 85-crore penalties
 
Ø  Govt to invest Rs 1 lakh cr in Railways in FY16

Ø  FTIL in talks to sell stake in ATOM, DGCX

Ø  Essar shows interest in Nokia’s Chennai plant

Ø  An amount of Rs 4.5 lakh crore stuck in tax appeals

Ø  Bharti Airtel raises Rs 1,925 cr from stake sale in tower unit

Ø  Insider trading norms to be applicable before listing

Ø  Per capita income rises to Rs. 88,533 in FY15

Ø  DLF says will challenge SEBI order 

Ø  Don’t differentiate in gas allocation for urea and NP/NPK fertilisers: FAI

Ø  NSE to set up global exchange at IFSC-GIFT in Gandhinagar 

Ø  Planters urge Centre to raise import duty on rubber to 30% 

Ø  Isha Ambani, Radhika Piramal on Forbes’ list of ‘power businesswomen’  
 
Ø  Power tariffs may rise after hike in freight rates for coal

Ø  RBS to shut down operations in India, 24 other countries

Ø  SBI gets shareholders nod for raising Rs15,000 crore from market

Ø  TPG to buy stake in Manipal Health for $146 million

Ø  Subdued sales hurt SKF India’s profit margin

Ø  Wockhardt says FDA raises new concerns about Waluj plant

Ø  Rail Budget disappoints markets, Sensex plunges 261 pts to close at 28,746 pts

Ø  Glut of perpetual bond issuances may push rates upwards of 10%

Ø  Jan Dhan overdraft eligible for priority sector lending: RBI

Ø  Amfi proposes 1% cap on upfront commission

Ø  India’s domestic IT market to touch $67 bn by 2020: Zinnov study
 
Ø  India Inc’s foreign borrowing up 44.5% in January

Ø  PPP policy must change to attract investment in railways: Prabhu

Ø  Oil cos suffer inventory loss of Rs 30K cr on price slump: FM

Ø  Lower diesel prices among reasons behind no hike in rail fares

Ø  Prabhu’s maiden Rail Budget gets thumbs up from India Inc

Ø  Glenmark gets USFDA nod to sell generic blood pressure drug
by -9.7%